CBD Shows Promise for Extending Healthy Lifespan in Preclinical Aging Models | Research

The takeaway

Preclinical research across multiple model organisms suggests cannabinoids, particularly CBD, can extend healthspan and lifespan through autophagy induction and antioxidant system activation.

Aging researchers; people interested in the science behind CBD and longevity claims.

CBD extended both healthspan and lifespan in C. elegans aging models

What the researchers found

CBD extends healthspan and lifespan in C. elegans and other model organisms. Mechanistic studies show CBD works through autophagy induction and activation of antioxidative systems. Emerging evidence also suggests cannabinoids may inhibit cellular senescence. CBD improved age-related behavioral dysfunction in both healthy and accelerated aging models.

Why it matters

With aging populations worldwide, anti-aging interventions that target fundamental aging processes could address multiple age-related diseases simultaneously. CBD's ability to extend healthspan in multiple model organisms, combined with its established safety profile in humans, makes it a particularly interesting candidate for translational aging research.

The numbers in context

The review covers research across approximately 105.3 million patients in reference studies and multiple preclinical model systems. Specific lifespan extension percentages vary by model organism and experimental conditions.

How the study worked

Narrative review synthesizing preclinical research on cannabinoids and aging across multiple model systems, with particular emphasis on studies using the nematode Caenorhabditis elegans. Examines endocannabinoid system involvement in aging regulation and exogenous cannabinoid effects on healthspan markers.

What this study cannot tell us

Most evidence comes from simple model organisms like C. elegans, which differ enormously from humans in biology and lifespan regulation. Translation to mammalian systems remains a critical gap. Human aging studies with cannabinoids are essentially non-existent.

How to read the evidence

Preliminary: consistent findings across preclinical model organisms, but minimal mammalian data and no human aging studies with cannabinoids.

When this study was published

2024 review.

The bigger picture

The endocannabinoid system declines with age, and this decline may contribute to aging processes. If exogenous cannabinoids can compensate for this decline, cannabis-derived compounds could join the small list of interventions (alongside caloric restriction and rapamycin) with demonstrated anti-aging effects across species.

Questions still open

Do CBD's lifespan-extending effects translate to mammalian models? What doses and timing of cannabinoid exposure would be needed for anti-aging benefits in humans? Do other cannabinoids beyond CBD have anti-aging properties?

Common questions

How does CBD potentially slow aging?

Mechanistic studies show CBD activates autophagy (cellular cleanup) and antioxidant defense systems, both of which decline with age. It may also inhibit cellular senescence, the process where cells stop dividing and release inflammatory signals that damage surrounding tissue.

Can CBD extend human lifespan?

There is no evidence for this yet. The findings come from simple organisms like roundworms. Translation to humans requires mammalian studies first, then clinical trials. The biological mechanisms are promising but the gap between worms and humans is vast.

Read the original research

Cannabinoids and healthy ageing: the potential for extending healthspan and lifespan in preclinical models with an emphasis on Caenorhabditis elegans.

GeroScience, 46(6), 5643-5661

View on PubMed ↗Publisher’s paper ↗

Citation

Wang, Zhizhen; Arnold, Jonathon C. (2024). Cannabinoids and healthy ageing: the potential for extending healthspan and lifespan in preclinical models with an emphasis on Caenorhabditis elegans.. GeroScience, 46(6), 5643-5661. https://doi.org/10.1007/s11357-024-01162-8